Menhaden Oil Decreases High-Fat Diet–Induced Markers of Hepatic Damage, Steatosis, Inflammation, and Fibrosis in Obese Ldlr−/− Mice

Adipocyte Gene Expression Is Altered in Formerly Obese Mice and As a Function of Diet Composition

(2018) Ryan S. Miller et al.   JOURNAL OF NUTRITION

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

(2011) V. Nobili et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Fish oil — How does it reduce plasma triglycerides?

(2011) Gregory C. Shearer et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Isoprostane Generation and Function

(2011) Ginger L. Milne et al.   CHEMICAL REVIEWS

Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis

(2011) Derrick M. Van Rooyen et al.   GASTROENTEROLOGY

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2011) Joel E. Lavine   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Histological features of non-alcoholic fatty liver disease: What is important?

(2011) Etsuko Hashimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

SREBP-2: A link between insulin resistance, hepatic cholesterol, and inflammation in NASH

(2011) Derrick M Van Rooyen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice

(2011) Savitha Subramanian et al.   JOURNAL OF LIPID RESEARCH

Inflammation meets cancer, with NF-κB as the matchmaker

(2011) Yinon Ben-Neriah et al.   NATURE IMMUNOLOGY

Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets

(2011) Barbara D. Pachikian et al.   PLoS One

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Macrophages, Inflammation, and Insulin Resistance

(2010) Jerrold M. Olefsky et al.   Annual Review of Physiology

Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential

(2010) Ananta Paine et al.   BIOCHEMICAL PHARMACOLOGY

Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation

(2010) Donald B. Jump et al.   BIOCHEMICAL PHARMACOLOGY

Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury

(2010) Tomonori Kishino et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Small molecule modulators of antioxidant response pathway

(2010) Wooyoung Hur et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Fatty acid regulation of hepatic lipid metabolism

(2010) Donald B Jump   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Epidemiology of Non-Alcoholic Fatty Liver Disease

(2010) Stefano Bellentani et al.   DIGESTIVE DISEASES

Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women

(2010) J Oya et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Treatment with Ω-3 fatty acids but not exendin-4 improves hepatic steatosis

(2010) Deepti G. Bulchandani et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study

(2010) Francesco Sofi et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model

(2010) Motoki Inoue et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

A fresh look at NASH pathogenesis. Part 1: The metabolic movers

(2010) Claire Z Larter et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese BL/6J mice

(2010) Sasmita Tripathy et al.   JOURNAL OF LIPID RESEARCH

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fatty liver: Role of inflammation and fatty acid nutrition

(2010) Christopher D Byrne   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes

(2009) Wendy L. Thompson et al.   BRAIN RESEARCH

Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome

(2009) C. H. KIM et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

The role of the lipogenic pathway in the development of hepatic steatosis

(2009) C. Postic et al.   DIABETES & METABOLISM

Up-Regulating the Hemeoxygenase System Enhances Insulin Sensitivity and Improves Glucose Metabolism in Insulin-Resistant Diabetes in Goto-Kakizaki Rats

(2009) Joseph Fomusi Ndisang et al.   ENDOCRINOLOGY

Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice

(2009) Jun Yu et al.   GASTROENTEROLOGY

Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats

(2009) Angelique Nicolai et al.   HYPERTENSION

Novel Eicosapentaenoic Acid-derived F3-isoprostanes as Biomarkers of Lipid Peroxidation

(2009) Wen-Liang Song et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of hepatic fatty acid elongase 5 by LXRα–SREBP-1c

(2008) Yan Qin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

(2008) Kristiaan Wouters et al.   HEPATOLOGY

Human Biochemistry of the Isoprostane Pathway

(2008) Ginger L. Milne et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS